SCHEMBL7697986

SCHEMBL7697986

O=COC(=O)c1cc(C(=O)OC=O)cc([N+](=O)[O-])c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
CYP3A4 P08684 1/20 0.50
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
PTPN6 P29350 1/20 0.49
PTPN11 Q06124 1/20 0.49
NPC1 O15118 1/20 0.47
GAA P10253 2/20 0.44
HTT P42858 1/20 0.44
PTGES O14684 1/20 0.44
KDM4E B2RXH2 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
POLB P06746 1/20 0.42
TP53 P04637 1/20 0.42
ATM Q13315 1/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15751973 0.98 ALOX5 (0.54) ALOX5SMN1; SMN2CYP3A4PTPN2PTPN1
SCHEMBL7697989 0.93 ALOX5 (0.50) ALOX5SMN1; SMN2CYP3A4PTPN2PTPN1
SCHEMBL7697991 0.93 ALOX5 (0.50) ALOX5SMN1; SMN2CYP3A4PTPN2PTPN1
SCHEMBL4533690 0.83 CES1 (0.57) PTPN2PTPN1GAAKDM4ETDP1
SCHEMBL11649570 0.81 ALOX5 (0.53) ALOX5SMN1; SMN2CYP3A4PTPN2PTPN1
SCHEMBL22615206 0.81 CA12 (0.37) GAAKDM4ETDP1POLBMAPT
SCHEMBL561284 0.78 HTT (0.64) ALOX5SMN1; SMN2NPC1GAAHTT
SCHEMBL7648958 0.78 CYP3A4 (0.61) ALOX5SMN1; SMN2CYP3A4PTPN2PTPN1
SCHEMBL6427641 0.78 CYP3A4 (0.61) ALOX5SMN1; SMN2CYP3A4PTPN2PTPN1
SCHEMBL7232896 0.77 ALOX5 (0.46) ALOX5SMN1; SMN2CYP3A4PTPN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002002520-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO disclosed